Despite similar IPA prevalence in critically ill patients with COVID-19 and influenza, the contribution of Aspergillus to the patient presentation in each illness might be different. In our patients with IPA, death, including in the two patients who received anti-Aspergillus treatment, was not related to aspergillosis but to bacterial septic shock complicated by multiorgan failure.